Johnson & Johnson pharmaceutical announced this Thursday () that will suspend in 2023 the sale of its baby powder around the world, two years after having made it in the United States and Canada, after being shaken by thousands of complaints about the safety of the product .
In a brief note, the company said it made the “commercial decision” to replace talc with cornstarch in this children’s product after receiving about 17 thousand lawsuits linking its long-term use to the development of cancer, although it continues to deny that this is the cause.
At the end of 2018, information has emerged indicating that J&J has known for decades that its powdered lco contained asbestos, a mineral with composition and characteristics similar to asbestos and with harmful effects on health.
Since then, J&J has faced thousands of lawsuits accusing the manufacturer of having contributed to the development of ovarian cancer in consumers, something the company denies and that each year leads her to spend millions of dollars in litigation.
“Our stance on the safety of our cosmetic powder remains unchanged. We strongly support decades of scientific analysis by medical experts around the world, confirming that Johnson’s baby talcum powder is safe, asbestos-free and cancer-free.”
The company faces other legal issues in the US and agreed earlier this year to pay millions of dollars to several states, along with other major drug distributors, for their responsibility in the opioid crisis.
Receive Our News
Newsletter On the cellphone
Get our newsletters
By registering for our newsletters, you agree to our Terms of Use and Privacy Policy, including receiving content and promotions from Gazeta do Povo. Unsubscribing can be done at any time at this link.